Fluorescence nanoparticles "quantum dots" as drug delivery system and their toxicity: A review

Journal of Drug Targeting

Volumn 19, Issue 7, 2011, Pages 475-486

  Ghaderi, Shirin ^a   Ramesh, Bala ^a   Seifalian, Alexander M ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON CENTRE FOR NANOTECHNOLOGY   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cancer; Drug delivery; Imaging; Quantum dots; Toxicity

Indexed keywords

CADMIUM; CADMIUM SELENIDE; CADMIUM TELLURIDE; INDIUM ARSENIDE; NANOCRYSTAL; NANOPARTICLE; QUANTUM DOT; THIOGLYCOLIC ACID; TRIOCTYLPHOSPHINE OXIDE; UNCLASSIFIED DRUG; ZINC SULFIDE;

BLOOD BRAIN BARRIER; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; ENCAPSULATION; FLUORESCENCE; HUMAN; IN VIVO STUDY; MEDICAL LITERATURE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; REVIEW; SYNTHESIS; TOXICITY;

DRUG DELIVERY SYSTEMS; FLUORESCENCE; NANOPARTICLES; QUANTUM DOTS;

EID: 79960527809     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.526227     Document Type: Review

References (53)

1. Alivisatos P. (2004). The use of nanocrystals in biological detection. Nat Biotechnol, 22, 47-52. (Pubitemid 38057955)
2. Bakalova R, Zhelev Z, Jose R, Nagase T, Ohba H, Ishikawa M, Baba Y. (2005). Role of free cadmium and selenium ions in the potential mechanism for the enhancement of photoluminescence of CdSe quantum dots under ultraviolet irradiation. J Nanosci Nanotechnol, 5, 887-894. (Pubitemid 41647849)
3. Bakhshi R, Edirisinghe MJ, Darbyshire A, Ahmad Z, Seifalian AM. (2009). Electrohydrodynamic jetting behaviour of polyhedral oligomeric silsesquioxane nanocomposite. J Biomater Appl, 23, 293-309.
4. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. (2004). Noninvasive imaging of quantum dots in mice. Bioconjug Chem, 15, 79-86. (Pubitemid 38165983)
5. Chaloupka K, Malam Y, Seifalian AM. (2010). Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol (In Press
6. Chan WH, Shiao NH, Lu PZ. (2006). CdSe quantum dots induce apoptosis in human neuroblastoma cells via mitochondrial-dependent pathways and inhibition of survival signals. Toxicol Lett, 167, 191-200.
7. Chen FQ, Gerion, D. (2004). Fluorescent CdSe/ZnS nanocrystal-peptide conjugates for long-term, nontoxic imaging and unclear targeting in living cells. Nano Lett, 4, 1827-1832.
8. Chen Z, Chen H, Meng H, Xing G, Gao X, Sun B, Shi X, Yuan H, Zhang C, Liu R, Zhao F, Zhao Y, Fang X. (2008). Bio-distribution and metabolic paths of silica coated CdSeS quantum dots. Toxicol Appl Pharmacol, 230, 364-371.
9. Cho SJ, Maysinger D, Jain M, Röder B, Hackbarth S, Winnik FM. (2007). Long-term exposure to CdTe quantum dots causes functional impairments in live cells. Langmuir, 23, 1974-1980. (Pubitemid 46406150)
10. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV. (2007). Renal clearance of quantum dots. Nat Biotechnol, 25, 1165-1170. (Pubitemid 47538116)
11. Deen WM, Lazzara MJ, Myers BD. (2001). Structural determinants of glomerular permeability. Am J Physiol Renal Physiol, 281, F579-F596.
12. Delehanty JB, Medintz IL, Pons T, Brunel FM, Dawson PE, Mattoussi H. (2006). Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. Bioconjug Chem, 17, 920-927. (Pubitemid 44162609)
13. Derfus AM, Chan WCW, Bhatia SN. (2003). Probing the cytotoxicity of semiconductor quantum dots. Nano Letters, 4, 11-18.
14. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. (2004). In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol, 22, 969-976. (Pubitemid 39014473)
15. Gopee NV, Roberts DW, Webb P, Cozart CR, Siitonen PH, Warbritton AR, Yu WW, Colvin VL, Walker NJ, Howard PC. (2007). Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol Sci, 98, 249-257. (Pubitemid 47078755)
16. Green M, Howman E. (2005). Semiconductor quantum dots and free radical induced DNA nicking. Chem Commun (Camb), 1, 121-123.
17. Fischer HC, Liu LC, Pang KS, Chan WC. (2006). Pharmacokinetics of nanoscale quantum dots: In vivo distribution, sequestration, and clearance in the rat. Adv Funct Mater, 16, 1299-1305. (Pubitemid 44049451)
18. Hardman R. (2006). A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect, 114, 165-172. (Pubitemid 43193634)
19. Hoshino A, Hanaki K, Suzuki K, Yamamoto K. (2004a). Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body. Biochem Biophys Res Commun, 314, 46-53. (Pubitemid 38058367)
20. Hoshino A, Fujioka K, Oku T, Suga M, Sasaki YF, Ohta T, Yasuhara M, Suzuki K, Yamamoto K. (2004b) Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Letters, 4, 2163-2169.
21. Iga AM, Robertson JH, Winslet MC, Seifalian AM. (2007). Clinical potential of quantum dots. J Biomed Biotechnol, 2007, 76087.
22. Ipe BI, Lehnig M, Niemeyer CM. (2005). On the generation of free radical species from quantum dots. Small, 1, 706-709. (Pubitemid 43951727)
23. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. (2003). Longterm multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol, 21, 47-51. (Pubitemid 36055826)
24. Jamieson T, Bakhshi R, Petrova D, Pocock R, Imani M, Seifalian AM. (2007). Biological applications of quantum dots. Biomaterials, 28, 4717-4732. (Pubitemid 47259173)
25. Juzenas P, Chen W, Sun YP, Coelho MA, Generalov R, Generalova N, Christensen IL. (2008). Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev, 60, 1600-1614.
26. Kidane AG, Burriesci G, Edirisinghe M, Ghanbari H, Bonhoeffer P, Seifalian AM. (2009). A novel nanocomposite polymer for development of synthetic heart valve leaflets. Acta Biomater, 5, 2409-2417.
27. Kirchner C, Liedl T, Kudera S, Pellegrino T, Muoz Javier A, Gaub HE, Stölzle S, Fertig N, Parak WJ. (2005). Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett, 5, 331-338. (Pubitemid 40308295)
28. Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW, Webb WW. (2003). Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science, 300, 1434-1436. (Pubitemid 36638163)
29. Lin P, Chen JW, Chang LW, Wu JP, Redding L, Chang H, Yeh TK, Yang CS, Tsai MH, Wang HJ, Kuo YC, Yang RS. (2008). Computational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in mice. Environ Sci Technol, 42, 6264-6270.
30. Lockman PR, Mumper RJ, Khan MA, Allen DD. (2002). Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm, 28, 1-13. (Pubitemid 34279373)
31. Longmire M, Choyke PL, Kobayashi H. (2008). Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond), 3, 703-717.
32. Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D. (2005). Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med, 83, 377-385. (Pubitemid 41201802)
33. Lovric J, Cho SJ, Winnik FM, Maysinger D. (2005). Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol, 12, 1227-1234. (Pubitemid 41628258)
34. Malam Y, Loizidou M, Seifalian AM. (2009). Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci, 30, 592-599.
35. Ohlson M, Sörensson J, Lindström K, Blom AM, Fries E, Haraldsson B. (2001). Effects of filtration rate on the glomerular barrier and clearance of four differently shaped molecules. Am J Physiol Renal Physiol, 281, F103-F113.
36. Pelley JL, Daar AS, Saner MA. (2009). State of academic knowledge on toxicity and biological fate of quantum dots. Toxicol Sci, 112, 276-296.
37. Riyahi-Alam N, Behrouzkia Z, Seifalian A, Haghgoo Jahromi S. (2010). Properties Evaluation of a New MRI Contrast Agent Based on Gd-Loaded Nanoparticles. Biol Trace Elem Res.
38. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. (2007). Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Dermatol, 127, 143-153. (Pubitemid 46005672)
39. Schipper ML, Cheng Z, Lee SW, Bentolila LA, Iyer G, Rao J, Chen X, Wu AM, Weiss S, Gambhir SS. (2007). microPET-based biodistribution of quantum dots in living mice. J Nucl Med, 48, 1511-1518. (Pubitemid 47397401)
40. Shiohara A, Hoshino A, Hanaki K, Suzuki K, Yamamoto K. (2004). On the cyto-toxicity caused by quantum dots. Microbiol Immunol, 48, 669-675. (Pubitemid 39264940)
41. Smith AM, Duan H, Mohs AM, Nie S. (2008). Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev, 60, 1226-1240.
42. Su Y, He Y, Lu H, Sai L, Li Q, Li W, Wang L, Shen P, Huang Q, Fan C. (2009). The cytotoxicity of cadmium based, aqueous phase-synthesized, quantum dots and its modulation by surface coating. Biomaterials, 30, 19-25.
43. Tang M, Xing T, Zeng J, Wang H, Li C, Yin S, Yan D, Deng H, Liu J, Wang M, Chen J, Ruan DY. (2008). Unmodified CdSe quantum dots induce elevation of cytoplasmic calcium levels and impairment of functional properties of sodium channels in rat primary cultured hippocampal neurons. Environ Health Perspect, 116, 915-922. (Pubitemid 351943899)
44. Tonks NK. (2005). Redox redux: revisiting PTPs and the control of cell signaling. Cell, 121, 667-670. (Pubitemid 40797589)
45. Voura EB, Jaiswal JK, Mattoussi H, Simon SM. (2004). Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med, 10, 993-998. (Pubitemid 39273742)
46. Wang L, Nagesha DK, Selvarasah S, Dokmeci MR, Carrier RL. (2008). Toxicity of CdSe Nanoparticles in Caco-2 Cell Cultures. J Nanobiotechnology, 6, 11.
47. Woodward JD, Kennel SJ, Mirzadeh S, Dai S, Wall JS, Richey T, Avenell J, Rondinone AJ. (2007). In vivo SPECT/CT imaging and biodistribution using radioactive (CdTe)-Te-125m/ZnS nanoparticles. Nanotechnology, 18, 175103-175108.
48. Yaghini E, Seifalian AM, MacRobert AJ. (2009). Quantum dots and their potential biomedical applications in photosensitization for photodynamic therapy. Nanomedicine (Lond), 4, 353-363.
49. Zhang Y, Chen W, Zhang J, Liu J, Chen G, Pope C. (2007). In vitro and in vivo toxicity of CdTe nanoparticles. J Nanosci Nanotechnol, 7, 497-503.
50. Zhang H, Yee D, Wang C. (2008). Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine (Lond), 3, 83-91. (Pubitemid 351611867)
51. Zhang LW, Yu WW, Colvin VL, Monteiro-Riviere NA. (2008). Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol, 228, 200-211.
52. Zhang T, Stilwell JL, Gerion D, Ding L, Elboudwarej O, Cooke PA, Gray JW, Alivisatos AP, Chen FF. (2006). Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. Nano Lett, 6, 800-808.
53. Zimmer JP, Kim SW, Ohnishi S, Tanaka E, Frangioni JV, Bawendi MG. (2006). Size series of small indium arsenide-zinc selenide core-shell nanocrystals and their application to in vivo imaging. J Am Chem Soc, 128, 2526-2527. (Pubitemid 43327916)